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Antigenicity of Recombinant Maltose Binding Protein-Mycobacterium
avium subsp. paratuberculosis Fusion Proteins with and without
Factor Xa Cleaving
Ratna B. Gurung,a,b Douglas J. Begg,a Auriol C. Purdie,a John P. Bannantine,c Richard J. Whittingtona
Faculty of Veterinary Science, University of Sydney, Camden, NSW, Australiaa; Department of Livestock, Ministry of Agriculture and Forests, Thimphu, Bhutanb; Bacterial
Diseases of Livestock Research Unit, USDA-ARS National Animal Disease Center, Ames, Iowa, USAc
Mycobacterium avium subsp. paratuberculosis causes Johne’s disease (JD) in ruminants. Proteomic studies have shown
that M. avium subsp. paratuberculosis expresses certain proteins when exposed to in vitro physiological stress conditions
similar to the conditions experienced within a host during natural infection. Such proteins are hypothesized to be ex-
pressed in vivo, are recognized by the host immune system, and may be of potential use in the diagnosis of JD. In this
study, 50 recombinant maltose binding protein (MBP)-M. avium subsp. paratuberculosis fusion proteins were evaluated
using serum samples from sheep infected with M. avium subsp. paratuberculosis, and 29 (58%) were found to be antigenic.
Among 50 fusion proteins, 10 were evaluated in MBP fusion and factor Xa-cleaved forms. A total of 31 proteins (62%) were
found to be antigenic in either MBP fusion or factor Xa-cleaved forms. Antigenicity after cleavage and removal of the MBP
tag was marginally enhanced.
Johne’s disease (JD) in ruminants is a chronic infection of theintestines caused by Mycobacterium avium subsp. paratubercu-
losis. Economic losses arise due to culling, reduced production of
milk and wool, and mortalities (1, 2). The disease is characterized
by a long incubation period, and subclinical infection creates a
potential source of infection for uninfected animals. The most
common method of detection of JD is by measuring immune
responses in the infected host. The two widely used assays to mea-
sure cell-mediated and antibody-mediated immune responses are
the gamma interferon (IFN-) assay and the enzyme-linked im-
munosorbent assay (ELISA), respectively. These depend on M.
avium subsp. paratuberculosis-specific antigens for stimulating
IFN- from memory T cells or detecting specific antibodies in
blood samples. Currently used antigens in these assays are French-
pressed proteins or purified protein derivatives (PPDs) derived
from whole cells of M. avium subsp. paratuberculosis, containing a
large number of antigens. The diagnostic specificity of commer-
cial antibody ELISAs is generally high, but sensitivity is poor (3, 4).
The accuracy of an ELISA also can be adversely affected by poten-
tial cross-reactions due to exposure of the host to environmental
mycobacteria. The specificity of an assay can be enhanced by ab-
sorbing the serum against Mycobacterium phlei proteins (5, 6).
However, it is difficult to enhance ELISA sensitivity due to the
poor Th2 responses during the lengthy latent period of the disease
and the large population of infected animals with latent subclini-
cal infections in an exposed flock or herd. Therefore, to enhance
assay performance, new M. avium subsp. paratuberculosis-specific
antigens that are expressed during latency need to be identified.
Evidence of dormancy in M. avium subsp. paratuberculosis
when the organism was present in the soil/pasture environment
was reported (7). In vitro studies simulating the stress conditions
of natural infection reported dormancy-associated proteins in M.
avium subsp. paratuberculosis (8–10). These findings led to a
hypothesis that M. avium subsp. paratuberculosis expresses stress/
dormancy-related proteins during infection of the host. The use of
M. avium subsp. paratuberculosis proteins that are expressed in
vivo following pathogen entry into the host as diagnostic antigens
may be of value in the detection of an early stage of M. avium
subsp. paratuberculosis infection. Indeed, some of the M. avium
subsp. paratuberculosis proteins known to be differentially regu-
lated under stress conditions were found to be antigenic in serum
collected from sheep infected with M. avium subsp. paratubercu-
losis, and these findings support the hypothesis that stress proteins
expressed in vitro are also expressed in vivo (11–13).
A large number of recombinant M. avium subsp. paratubercu-
losis antigens have been investigated for their diagnostic potential
in cell- and antibody-mediated assays (11, 13–22). Some of these
M. avium subsp. paratuberculosis proteins were from groups of
proteins that were differentially regulated under physiological
stress conditions. Although many proteins were found to be anti-
genic, no obvious candidate has yet been identified as having suit-
able diagnostic sensitivity and specificity.
A major limitation for characterization of recombinant M.
avium subsp. paratuberculosis proteins is their expression as inclu-
sion bodies or insoluble proteins, especially when prepared using
histidine (His) as an affinity purification tag (13). Production of
antigens from insoluble proteins involves processes that may be
detrimental to biological activity. Expression of maltose binding
protein (MBP) fusion proteins facilitates maintenance of the sol-
ubility, structure, and functions of recombinant proteins through
downstream processing (23, 24). Several recombinant MBP-M.
avium subsp. paratuberculosis fusion proteins (MBP fusion pro-
teins) were found to be antigenic in sheep, cattle, and mice in-
fected with M. avium subsp. paratuberculosis (15, 16, 25). How-
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ever, MBP alone, with a molecular mass of about 42.5 kDa, is
known to have a small amount of seroreactivity; because of this, it
must be used as a control in ELISAs (23). Furthermore, it is not
known if the MBP protein masks the immune recognition of a
protein of interest. Therefore, cleavage of the MBP tag from the
recombinant M. avium subsp. paratuberculosis proteins may be
beneficial for their use.
Factor Xa is a protease that specifically cleaves after the argi-
nine residue in its preferred site Ile-(Glu or Asp)-Gly-Arg se-
quence (26) and can be used to separate the MBP affinity purifi-
cation tag from the protein of interest following expression and
purification (27, 28). This protease was used in the current study
for removal of the MBP purification tag. The aims of this study
were to evaluate the antigenicity of M. avium subsp. paratubercu-
losis recombinant proteins hypothesized to be upregulated under
stress conditions and to investigate their potential use in early
diagnosis. These proteins were examined with and without the
MBP tag to determine if the proteins cleaved of MBP had better
antigenicity, and some were compared with the corresponding
His-tagged recombinant protein.
MATERIALS AND METHODS
Antigens. The M. avium subsp. paratuberculosis proteins in this study
(Table 1) were selected based on their expression in response to in vitro
physiological stress conditions (8–10). Fifty M. avium subsp. paratuber-
culosis recombinant proteins used in this study were produced as MBP
fusion proteins at the Bacterial Diseases of Livestock Research Unit,
USDA-ARS Agricultural Research Service National Animal Disease Cen-
ter (NADC) (Ames, IA), and one (MAP1272c) was produced as a His-
tagged recombinant M. avium subsp. paratuberculosis protein (29). The
MBP fusion proteins were produced as described previously (30). Briefly,
the full-length coding sequence of the M. avium subsp. paratuberculosis
protein was amplified using gene-specific primers and was cloned into the
pMAL-c2 translational fusion expression vector. The vector and amplified
products were digested with XbaI and HindIII, and the ligated products
were transformed into Escherichia coli DH5 cells. The overexpressed
proteins were extracted and purified by affinity chromatography with
amylose resin columns (New England BioLabs). Three His-tagged
recombinant M. avium subsp. paratuberculosis proteins (MAP2698c,
MAP2487c, and MAP3567) were produced at the Faculty of Veterinary
Science, University of Sydney (Sydney, Australia), as previously described
(12). Briefly, gene-specific primers were designed to include attB1 and
attB2 sites at the 5= end of each sequence. The complete open reading
frames of each gene were amplified by PCR using Gateway technology
(Invitrogen, Australia). Amplified and purified PCR products were
cloned into the donor vector pDONR221 (Invitrogen, Australia) and
transformed into One Shot TOP10 chemically competent E. coli cells
(Invitrogen, Australia) to produce an entry clone. Purified entry clones
were subcloned into the destination vector pET160-DEST with an N-
terminal 6His and Lumio tag (Champion pET160 Gateway expres-
sion kit with Lumio technology; Invitrogen, Australia) and trans-
formed into One Shot TOP10 chemically competent E. coli cells to
produce an expression clone. One Shot BL21 Star (DE3) cells (Invit-
rogen, Australia) were transformed with the purified expression clone.
The transformed culture was induced with 1 mM isopropyl--1-thio-
galactopyranoside to express the recombinant proteins. Recombinant
proteins were extracted and purified by affinity liquid chromatography
(AKTApurifier system; GE Healthcare). The four His-tagged recom-
binant M. avium subsp. paratuberculosis proteins (1 from the NADC
and 3 from the University of Sydney) were compared with the corre-
sponding MBP fusion proteins.
Proteolytic cleavage of MBP fusion proteins. A pilot study was per-
formed with MBP fusion proteins (MAP0435c, MAP1846c, and
MAP1017c) to determine the optimal time for enzymatic cleavage of the
M. avium subsp. paratuberculosis protein from the MBP tag. Factor Xa
(Amersham Biosciences) was reconstituted to a final concentration of 1
unit/l in nuclease-free water at 4°C. MBP fusion proteins were diluted to
1 mg/ml in phosphate-buffered saline (PBS). Factor Xa (1 l) was added
to the MBP fusion protein (100 l) in a 1.5-ml screw-cap tube and mixed
briefly with a vortex mixer. Reaction buffer (100 l) was added to the
mixture, which was vortex mixed briefly and incubated for 16 to 40 h at
room temperature (RT) (22 to 24°C). Fifteen-microliter aliquots were
collected after 16, 18, 20, 25, 30, 35, and 40 h of incubation for SDS-PAGE
analysis. The optimal cleavage time was determined for each protein based
on the appearance of two bands that corresponded to the expected mo-
lecular masses of MBP and the relevant M. avium subsp. paratuberculosis
protein.
Due to the limited volume (500 l) of MBP fusion proteins, only 22
proteins with volumes and concentrations adequate for cleavage and an-
tigenicity evaluation were available. A reaction mixture containing 1 ml of
MBP fusion protein (1 mg), 10 l (10 units) of factor Xa, and 1 ml of
reaction buffer in a 5-ml screw-cap tube was prepared, vortex mixed
briefly, and incubated for up to 40 h at RT. Aliquots of 15 l were collected
at various incubation times (16, 18, 20, 25, 30, and 40 h) and examined by
SDS-PAGE.
SDS-PAGE analysis. SDS-PAGE analyses of proteins were performed
using 12% precast polyacrylamide gels (Mini-PROTEAN TGX precast
gel, product no. 456-1043; Bio-Rad). Briefly, a 15-l aliquot of each pro-
tein sample (MBP-LacZ, MBP-M. avium subsp. paratuberculosis fusion
protein, factor Xa-cleaved M. avium subsp. paratuberculosis protein, pu-
TABLE 1 Evaluation and comparison of recombinant M. avium subsp.
paratuberculosis proteins (MBP fusion and His-tagged proteins)
Protein type and function Protein(s)
MBP fusion proteins
Phosphate metabolism MAP0435c
Cold shock protein MAP0810
Putative virulence factor MAP1272c
Universal stress proteins MAP1339
Cell wall synthesis MAP2058c
Signal recognition MAP3968
ATP and purine biosynthesis MAP2450c, MAP3393c
Cell division MAP0068, MAP1889c
Heat shock protein chaperone MAP3268, MAP3701c
Response regulators MAP0834c, MAP3200
Protein synthesis MAP1027c, MAP4125
Proteolysis MAP1834c, MAP2280c, MAP2281c
Amino acid metabolism MAP1293, MAP1297, MAP1846c,
MAP2864c
Antioxidant enzymes MAP1588c, MAP1589c, MAP1653,
MAP4340
Hypothetical protein MAP0593c, MAP0184c, MAP1586,
MAP3555, MAP3864
Fatty acid metabolism MAP0508, MAP0516c, MAP1017c,
MAP2698c, MAP2872c,
MAP3190, MAP3577,
MAP3651c
Cellular processes MAP0187c, MAP0540, MAP1560,
MAP1885c, MAP2411,
MAP2487c, MAP2705c,
MAP3007, MAP3538, MAP3567
His-tagged proteins
Putative virulence factor MAP1272c
Fatty acid metabolism MAP2698c
Cellular processes MAP2487c, MAP3567
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rified MBP, or purified M. avium subsp. paratuberculosis protein) was
placed in a 1.5-ml screw-cap tube. The protein samples were mixed with 3
l of reducing sample buffer and heated for 5 min in a boiling water bath.
Protein samples (18 l) were loaded onto a precast gel, and electrophore-
sis was performed at a constant voltage of 180 V (SmartPower 4000 power
pack) for 65 min or until the visible line of bromphenol blue reached the
bottom of the gel, using a Mini-PROTEAN 3 cell system (Bio-Rad). Pro-
tein bands were stained with Coomassie brilliant blue (0.1% Coomassie
brilliant blue G-250, 3% ortho-phosphoric acid, 10% ammonium sulfate,
and 20% methanol). The protein bands were visualized with a Geldoc
system (Bio-Rad).
Affinity chromatography purification of cleaved proteins. Purifica-
tion of cleaved MBP fusion proteins was performed with an AKTApurifier
fast performance liquid chromatography (FPLC) system (GE Healthcare)
using a MBPTrap HP dextran-Sepharose high performance column (5 ml;
GE Healthcare), following the manufacturer’s manual. Briefly, the col-
umn was equilibrated with 5 column volumes (CVs) of binding buffer at
a flow rate of 2 ml/min. A cleaved protein sample solution (1 ml) was
applied using a 1-ml sample loop, followed by washing with 5 CVs of
binding buffer to remove unbound protein (M. avium subsp. paratuber-
culosis protein), at a flow rate of 5 ml/min. The flowthrough protein peaks
were collected in 2-ml fractions. The bound MBP was eluted with 5 CVs of
elution buffer at a flow rate of 5 ml/min, and protein peaks were collected
in 2-ml fractions. The column was reequilibrated with 5 CVs of binding
buffer at a flow rate of 5 ml/min. The cleaved and purified M. avium subsp.
paratuberculosis proteins were dialyzed against PBS overnight at 4°C using
a 12-kDa-cutoff membrane tube. Proteins were concentrated by centri-
fuging the dialyzed protein solution at 2,000  g for 10 min at 4°C (Alle-
graX-12R; Beckman Coulter), using Amicon Ultra-15 centrifugal filter
units (nominal molecular mass limit of 10 kDa). The protein yield in the
retentate was estimated using a spectrophotometer (NanoDrop 1000;
Thermo Scientific) set at 280 nm.
Serum samples. A total of 46 sheep serum samples were obtained
from the serum archive maintained at the Faculty of Veterinary Science,
University of Sydney. Twenty-three serum samples were from unexposed/
uninfected sheep from Western Australia (31) that were certified to be free
of JD based on the negative test results for their flocks. Another 23 serum
samples were obtained from exposed/infected sheep that either tested
positive by tissue/fecal culture or had histopathological lesions consistent
with ovine JD. Serum samples obtained from infected animals also tested
positive with the Institut Pourquier ELISA (32), with a sample-to-positive
ratio of 70%, and were categorized as strong reactors (n  8), medium
FIG 1 SDS-PAGE analysis of pilot scale factor Xa cleavage of MBP fusion proteins. (A) MBP-MAP0435c; (B) MBP-MAP1017c; (C) MBP-MAP1846. Lanes 1,
molecular mass markers (PageRuler Plus prestained protein ladder); lanes 2, MBP-LacZ (54 kDa); lanes 3, MBP-M. avium subsp. paratuberculosis fusion protein
before cleavage; lanes 4 to 10, MBP-M. avium subsp. paratuberculosis fusion proteins cleaved at different time points, i.e., 16 h (lanes 4), 18 h (lanes 5), 20 h (lanes
6), 25 h (lanes 7), 30 h (lanes 8), 35 h (lanes 9), and 40 h (lanes 10).
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reactors (n  8), or low reactors (n  7). The infected sheep were fecal
culture positive (shedder; n  15) or negative (nonshedder; n  8). His-
topathological lesions were categorized according to a previously de-
scribed method (33), as follows: no or low-grade lesion (grade 0 to 2; n 
4), paucibacillary lesion (grade 3a plus grade 3c; n  2 	 8), or multiba-
cillary lesion (grade 3b; n  9).
Positive- and negative-control sheep sera were obtained from sheep
from the University of Sydney that were in an independent experimental
infection trial (34). The negative-control serum was obtained from a
sheep not exposed to M. avium subsp. paratuberculosis that had tested
negative by fecal culture, biopsied tissue culture, histopathological analy-
sis, and ELISA. Positive-control serum was obtained from a Gudair vac-
cine-immunized sheep, and the serum was determined to be positive by
the Institut Pourquier ELISA.
ELISA methodology. Antibody ELISA was performed to evaluate
the seroreactivity of MBP fusion proteins, cleaved M. avium subsp.
paratuberculosis proteins, and His-tagged recombinant M. avium
subsp. paratuberculosis proteins, using serum samples from M. avium
subsp. paratuberculosis-infected and uninfected sheep. Briefly, 50 l/
well of antigen at the specified final concentrations of MBP fusion
antigens (see Tables 3 and 4), cleaved M. avium subsp. paratuberculosis
antigens (5 g/ml) (see Table 4), or His-tagged M. avium subsp. para-
tuberculosis antigens (see Table 5) in carbonate buffer (0.1 M carbon-
ate buffer [pH 9.6]) were coated on 96-well flat-bottom microplates
(Nunc MaxiSorp; Nunc) and incubated overnight at 4°C. The plates
were machine washed 5 times with purified reverse-osmosis (RO) wa-
ter with Tween 20. ELISA plates coated with MBP fusion proteins and
MBP-LacZ were blocked with 4% skim milk, and plates coated with
cleaved M. avium subsp. paratuberculosis proteins and His-tagged M.
avium subsp. paratuberculosis proteins were blocked with 1% (vol/vol)
fetal calf serum (FCS) for 30 min each.
The serum samples were diluted (1:100) in a diluent (0.1% [vol/vol]
FCS in PBS with Tween 20 [PBST]) containing 1.3 mg/ml heat-killed M.
phlei protein (Elizabeth Macarthur Agricultural Institute, New South
Wales, Australia) and were absorbed overnight at 4°C, with constant end-
to-end shaking. The absorbed serum was centrifuged at 2,500  g for 10
min at RT to separate the supernatant from the particulate M. phlei. The
absorbed serum supernatant (50 l) was added to the required wells and
incubated for 1 h at RT. The plate was machine washed 5 times with RO
water with Tween 20 prior to the addition of horseradish peroxidase-
labeled mouse anti-sheep IgG monoclonal antibody conjugate (50 l,
1:40,000, clone GT-34; Sigma, New South Wales, Australia) in diluent
(0.1% [vol/vol] FCS in PBST) and then incubated for 1 h at RT. The plate
was machine washed as described above, and 100 l of 3,3=,5=,5=-tetra-
methylbenzidine (TMB) substrate was added. The plate was incubated for
20 min in the dark, after which the chromogenic reaction was stopped
with the addition of stop solution (50 l of 2 M sulfuric acid). The optical
density at 450 nm (OD450) was measured using a plate reader (Multiskan
Ascent; Thermo Scientific, Victoria, Australia). Serum samples were also
tested with MBP-LacZ (5 g/ml) to examine seroreactivity to MBP. The
ELISA results are presented as mean OD450 values.
Data analysis. Statistical analysis was performed using GenStat 12.1
(VSN International Ltd., United Kingdom) and GraphPad Prism 4.0
(GraphPad Software Inc., La Jolla, CA) software. The seroreactivities of
MBP fusion antigens, factor Xa-cleaved M. avium subsp. paratuberculosis
antigens, and His-tagged M. avium subsp. paratuberculosis antigens be-
tween groups were compared by analysis of variance (ANOVA) with a
Bonferroni correction for multiple comparisons, as described previously
(35). The area under the receiver operating characteristic curve
(AUCROC) was calculated for the ability of an assay using each antigen to
discriminate between uninfected and M. avium subsp. paratuberculosis-
infected sheep. An assay with an AUCROC value of 1.0 is considered to be
perfect, and one with a value of 0.5 is considered worthless (36).
RESULTS
Cleavage of MBP fusion proteins on a pilot scale. Three MBP
fusion proteins were cleaved by factor Xa protease in a pilot study
and analyzed by SDS-PAGE (Fig. 1A to C). Factor Xa was able to
cleave MBP-MAP0435c and MBP-MAP1017c after 16 h of incu-
bation at RT. Factor Xa was able to cleave MBP-MAP1846 com-
pletely only after 30 h of incubation. Cleavage of all three fusion
proteins revealed the expected band sizes for MBP (42.5 kDa) and
M. avium subsp. paratuberculosis proteins. However, multiple
bands were observed for the proteins MAP0435c and MAP1017c.
The pilot study showed that different proteins required different
cleavage times.
Cleavage of MBP fusion proteins on a large scale. Twenty-two
MBP fusion proteins were cleaved by factor Xa at different incu-
bation times. Eleven proteins were completely cleaved with 16 h of
incubation, six proteins required 20 h, and five proteins required
40 h for complete cleavage (Table 2). The SDS-PAGE analyses of
cleaved products are shown in Fig. 2A to F. For each MBP fusion
protein, the MBP tag was separated from the M. avium subsp.
paratuberculosis protein of expected molecular mass. Four pro-
TABLE 2 Expected molecular masses of MBP fusion and cleaved
proteins
Cluster Protein CTa (h)
Molecular mass (kDa) of:
Fusion
proteinb
M. avium subsp.
paratuberculosis
protein
Amino acid metabolism MAP1297 40 67.8 25.3
MAP1846c 40 73 30.5
Antioxidant enzymes MAP1588c 20 61.3 18.8
MAP1589c 16 64.1 21.6
MAP1653 16 58.9 16.4
ATP biosynthesis MAP3393c 20 60 17.5
Cell division MAP0068 40 60 17.5
Cellular processes MAP1560 16 57.7 15.2
MAP1885c 16 60.9 18.4
MAP2411 16 58 15.5
MAP2705c 20 56.4 13.9
MAP3538 16 58.4 15.9
Fatty acid metabolism MAP1017c 16 70.3 27.8
MAP2698c 20 73.9 31.4
MAP3190 16 75.8 33.3
Heat shock protein MAP3268 16 58.9 16.4
MAP3701c 40 58.7 16.2
Hypothetical protein MAP0593c 40 57.3 14.8
MAP3555 16 61.3 18.8
Phosphate metabolism MAP0435c 16 61.1 18.6
Proteolysis MAP2280c 20 65.7 23.2
Universal stress proteins MAP1339 20 57.9 15.4
a CT, cleavage time.
b Fusion protein mass is the total mass of MBP (42.5 kDa) and the M. avium subsp.
paratuberculosis protein.
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teins, i.e., MBP-MAP0593c, MBP-MAP3701c, MBP-MAP1297,
and MBP-MAP0068c, showed weak bands of undigested fusion
proteins even with 40 h of incubation. Fusion proteins such as
MBP-MAP0435c, MBP-MAP3393c, MBP-MAP3268, MBP-
MAP1653, MBP-MAP1846, MBP-MAP2280c, MBP-MAP1885c,
and MBP-MAP0068c were found to be cleaved, but there were
multiple bands of M. avium subsp. paratuberculosis proteins.
SDS-PAGE analysis of cleaved and purified proteins. Due to
the limited volumes of MBP fusion proteins received from the
USDA Agricultural Research Service (500 l each), only 22 pro-
teins were used for factor Xa cleavage experiments. Of 22 cleaved
proteins, only 10 proteins had adequate volumes for affinity liquid
chromatography purification.
The flowthrough (cleaved M. avium subsp. paratuberculosis
proteins) and eluate (cleaved MBP tag) fractions were verified by
SDS-PAGE analysis (Fig. 3A to E). The expected molecular masses
are shown in Table 2 and Fig. 3A to E. All of the cleaved M. avium
subsp. paratuberculosis proteins were obtained with 95% purity,
based on the band appearance on SDS-PAGE analysis. The yields
of purified and concentrated M. avium subsp. paratuberculosis
proteins were approximately 20 g/ml (MAP2698c and MAP3555),
30 g/ml (MAP1846, MAP1885c, and MAP2280c), 40 g/ml
(MAP1017c and MAP0593c), 60 g/ml (MAP3538), or 70 g/ml
(MAP1588c and MAP3190). Separated bands for cleaved M.
avium subsp. paratuberculosis proteins MAP1846, MAP1885c,
and MAP3555 were faint, due to the low protein concentrations.
Antigenicity of MBP fusion proteins. Fifty MBP fusion pro-
teins were evaluated, and 29 (58%) were found to be detected by
antibodies in sera obtained from M. avium subsp. paratuberculo-
sis-infected sheep (Tables 3 and 4). The remaining 42% (21/50) of
the proteins were not able to differentiate infected from unin-
fected animals. The seroreactivity of the control MBP-LacZ was
not significantly different in the infected and uninfected groups
(P  0.05). The greatest ability to differentiate the infected group
from the uninfected group was observed for the MAP0516c pro-
tein, which is encoded by echA20 and is involved in fatty acid
metabolism (AUCROC  0.758, P  0.001), MAP2872c, which is
encoded by fabG5 and is a 3-ketoacylreductase (AUCROC  0.765,
P  0.001), and MAP1834c, which is encoded by prcA and is a
proteome subunit protein (AUCROC  0.765, P  0.002).
Among the MBP fusion proteins evaluated, 19/50 (38%)
were able to produce significantly higher OD values in serum
samples obtained from sheep with paucibacillary infections,
compared with sera from unexposed sheep (P 
 0.05). Simi-
FIG 2 SDS-PAGE of factor Xa-cleaved M. avium subsp. paratuberculosis proteins. Lanes 1, molecular mass markers (PageRuler Plus prestained protein ladder);
lanes 2, MBP-LacZ; lanes 3, 5, 7, and 9, MBP-M. avium subsp. paratuberculosis fusion proteins; lanes 4, 6, 8, and 10, factor Xa-cleaved MBP and M. avium subsp.
paratuberculosis proteins.
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larly, 26/50 proteins (52%) were able to produce significantly
higher OD values in serum samples that were low reactors in
the Institut Pourquier ELISA, in comparison with sera from
unexposed sheep (P 
 0.05) (Tables 3 and 4). However, none
of the proteins was able to detect infections that were associ-
ated with no or low-grade lesions.
Antigenicity of cleaved and MBP fusion proteins. Success-
fully cleaved and purified M. avium subsp. paratuberculosis pro-
teins were evaluated and ELISA results were compared with those
for fused forms (Table 4). The OD values of infected sheep sera
were significantly higher than those of the uninfected sheep sera
for all factor Xa-cleaved proteins except MAP1885c. The MBP
fusion proteins MAP0593c and MAP2698c were not able to dif-
ferentiate between infected and uninfected sheep, but when they
were evaluated as cleaved proteins purified from the MBP fusion
proteins, the OD values of the infected group were significantly
higher (P 
 0.05) than those of the uninfected group. Protein
MAP1885c was not able to differentiate between the infected and
uninfected groups in either the fused or cleaved forms. Based on
AUCROC values, factor Xa cleavage did not enhance the immuno-
reactivity of four proteins (MAP1846, MAP1588c, MAP1885c,
and MAP3555). The M. avium subsp. paratuberculosis-specific
immunoreactivity of two proteins (MAP2698c and MAP0593c)
was enhanced while that of three proteins (MAP3538, MAP1017c,
and MAP2280c) was marginally enhanced by cleavage of MBP. In
general, the ability of cleaved proteins to differentiate the infected
and uninfected groups was enhanced in only 50% of the proteins
(5/10 proteins).
Antigenicity evaluation of His-tagged recombinant M.
avium subsp. paratuberculosis proteins. All four His-tagged re-
combinant M. avium subsp. paratuberculosis proteins were able to
differentiate between the infected and uninfected sheep sera (P 

0.05) (Table 5). The order of most antigenic to least antigenic pro-
teins was MAP1272c  MAP3567  MAP2487c  MAP2698c,
with AUCROC values of 0.90, 0.75, 0.70, and 0.69, respectively.
The seroreactivity of two different protein expression systems
(His tag and MBP fusion) were compared for MAP2698c,
MAP1272c, MAP2487c, and MAP3567. All four proteins were
able to differentiate between the infected and uninfected groups of
sheep in both expression systems. The OD values obtained from
an infected group of sheep using His-tagged recombinant proteins
were significantly higher (P 
 0.05) than those obtained using the
corresponding MBP fusion proteins (Table 6).
The ELISA results obtained from the infected sheep using
MAP2698c protein as a MBP fusion, factor Xa-cleaved, or His-
tagged protein were analyzed by one-way ANOVA with a Bonfer-
roni correction for multiple comparisons. The OD values ob-
tained using factor Xa-cleaved M. avium subsp. paratuberculosis
proteins and His-tagged M. avium subsp. paratuberculosis pro-
teins were significantly higher than those obtained with MBP fu-
FIG 3 SDS-PAGE of factor Xa-cleaved and purified MBP fusion proteins. Lanes 1, molecular mass markers (PageRuler Plus prestained protein ladder) (M); lanes
2, MBP-LacZ; lanes 3 to 10, proteins shown as MBP fusion protein and factor Xa-cleaved protein, eluate, and flowthrough fraction.
Gurung et al.
1822 cvi.asm.org Clinical and Vaccine Immunology
sion proteins (P 
 0.001). The OD values obtained with factor
Xa-cleaved M. avium subsp. paratuberculosis proteins and His-
tagged M. avium subsp. paratuberculosis proteins were similar
(P  0.05).
DISCUSSION
This study investigated the antigenicity of M. avium subsp. para-
tuberculosis proteins in either MBP-fused, factor Xa-cleaved, or
His-tagged forms, using sera that were known to have M. avium
subsp. paratuberculosis-specific antibodies, as detected by the
commercial Institut Pourquier ELISA (32). The proportion of an-
tigenic proteins increased from 58% to 62% after factor Xa cleav-
age. Sufficient amounts of MBP fusion proteins were available for
22 proteins to be cleaved using factor Xa. Ten of 22 proteins were
successfully purified and evaluated in both MBP fusion and factor
Xa-cleaved forms. Four proteins were evaluated in the His-tagged
form to compare the expression systems.
Factor Xa cleaves proteins after the arginine residue in its pre-
ferred cleavage site Ile-(Glu or Asp)-Gly-Arg in the fusion link
between MBP and the target protein. However, reports suggest
that it quite often cleaves at secondary sites, depending on the
conformation of the protein substrate (37, 38). The most com-
mon secondary site is Gly-Arg, usually in a partially unfolded pro-
tein (39). The probable cause of the appearance of multiple bands
on SDS-PAGE gels in this study may be proteolysis or cleavage of
target proteins at such secondary sites. Furthermore, on screening
of the amino acid sequences of proteins that showed multiple
bands on SDS-PAGE gels, several such sites were identified in
proteins MAP0435c, MAP1846, and MAP1017c. MAP0435c had
two Gly-Arg sites (amino acid positions 24-25 and 142-143),
MAP1846 had three Gly-Arg sites (amino acid positions 68-69,
99-100, and 159-160), and MAP1017c had one Gly-Arg site
(amino acid positions 168-169).
The protein cleavage experiment showed that 1 unit of fac-
tor Xa was sufficient to cleave 100 g of MBP fusion protein
after as little as 18 h of incubation at RT (22 to 23°C), and this
finding was consistent with the findings from another study
(40). However, factor Xa cleavage was not complete even after 40
h of incubation for proteins MBP-MAP0068c, MBP-MAP0593c,
MBP-MAP1297, MBP-MAP1846c, and MBP-MAP3701c. The
probable causes of incomplete cleavage may be an inaccessible
factor Xa recognition site or alteration of the factor Xa recognition
site during cloning (41). This process of protein cleavage, and
particularly the need for such long cleavage times, is not well un-
derstood, and further investigation may be useful.
Factor Xa is a heterodimer protease composed of two disulfide-
linked polypeptide chains with apparent molecular masses of 17
and 42 kDa (42). In this study, no obvious bands of these sizes
were observed, which may be due to too low a concentration to be
detected in SDS-PAGE analysis. Thus, removal of factor Xa using
p-aminobenzamidine resin was not necessary. ELISA results for
MBP fusion proteins were analyzed using OD values obtained for
MBP fusion proteins without subtracting the OD values obtained
for MBP-LacZ to allow for a comparative analysis between the
MBP fusion proteins and the factor Xa-cleaved forms. This was
justified, as levels of seroreactivity to MBP-LacZ were not signifi-
cantly different between infected and uninfected samples.
The MBP fusion proteins evaluated in this study were previ-
ously reported to be differentially regulated under different in
vitro stress conditions (8–10). More than one-half of the 50 MBP
fusion proteins evaluated were found to be antigenic, suggesting
that the majority of these proteins are expressed by M. avium
subsp. paratuberculosis in vivo and are recognized by the host im-
mune response. A recent study on the antigenicity of some of these
proteins expressed as His-tagged recombinant proteins showed
that 66% of the proteins (18/27 proteins) were detected by sera
from M. avium subsp. paratuberculosis-infected sheep (13). Of
those 27 proteins, 22 were included in this study. The proteins that
were found to be antigenic in both studies are MAP0516c,
TABLE 3 Antigenicity evaluation of MBP fusion proteins
Protein
Protein
concn
(g/ml)
OD450 (n) for:
Pc AUCROC
Unexposed
samples
(23)
Exposed
samples
(23)
MAP0068a 5 0.133 0.218 0.002 0.71
MAP0184ca,b 10 0.215 0.355 0.002 0.745
MAP0187c 5 0.236 0.31 0.118
MAP0435c 20 0.278 0.291 0.797
MAP0508a,b 6 0.3 0.501 0.004 0.713
MAP0516ca,b 5 0.257 0.439 
0.001 0.758
MAP0540 7 0.298 0.36 0.238
MAP0810 10 0.187 0.241 0.111
MAP0834ca,b 5 0.141 0.216 0.002 0.742
MAP1027c 10 0.176 0.234 0.083
MAP1272ca,b 10 0.26 0.451 0.005 0.703
MAP1293a,b 5 0.186 0.292 0.012 0.717
MAP1297a,b 10 0.172 0.321 0.002 0.744
MAP1339 5 0.204 0.274 0.067
MAP1560 10 0.252 0.273 0.51
MAP1586 5 0.285 0.311 0.515
MAP1589c 10 0.183 0.269 0.02 0.677
MAP1653b 10 0.195 0.263 0.045 0.683
MAP1834ca,b 9 0.262 0.44 0.002 0.765
MAP1889c 5 0.215 0.203 0.652
MAP2058ca,b 6 0.265 0.442 0.005 0.703
MAP2281c 7 0.29 0.281 0.773
MAP2411 10 0.265 0.298 0.481
MAP2450ca,b 8 0.202 0.293 0.045 0.677
MAP2487c 8 0.307 0.331 0.576
MAP2705c 10 0.208 0.228 0.541
MAP2864ca,b 8 0.336 0.455 0.035 0.658
MAP2872ca,b 8 0.166 0.289 
0.001 0.765
MAP3007a,b 7 0.211 0.357 0.003 0.74
MAP3200b 10 0.216 0.339 0.008 0.699
MAP3268 10 0.272 0.229 0.386
MAP3393c 10 0.261 0.291 0.497
MAP3567a,b 1 0.137 0.234 0.002 0.728
MAP3577 7 0.194 0.215 0.465
MAP3651ca,b 5 0.208 0.323 0.01 0.695
MAP3701c 10 0.166 0.198 0.274
MAP3864b 10 0.208 0.289 0.048 0.642
MAP3968a,b 7 0.154 0.277 0.002 0.719
MAP4125 10 0.284 0.292 0.847
MAP4340b 10 0.194 0.296 0.006 0.732
a Proteins able to produce significantly higher OD values for serum samples obtained
from sheep with paucibacillary infections than for serum samples from unexposed
sheep.
b Proteins able to produce significantly higher OD values for serum samples that were
low reactors in the Institut Pourquier ELISA than for serum samples from unexposed
sheep.
c Mean OD values for the exposed group are significantly higher than those for the
unexposed group (P 
 0.05).
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MAP0834c, MAP1846c, MAP2450c, MAP3200, and MAP3555.
The proteins that were found to be nonantigenic in both studies
are MAP1339, MAP1885c, MAP1889c, MAP2705c, MAP3701c,
MAP3577, and MAP4125. The proteins MAP0435c, MAP0593c,
MAP1027c, MAP2281c, and MAP2411 were found to be antigenic
by Kawaji et al. (13) but were not antigenic in this study. Similarly,
proteins MAP0068, MAP2007, MAP2864c, and MAP3864 were
found to be antigenic in this study but not by Kawaji et al. (13).
Disagreement in the results for the remaining proteins may be
attributed to factors such as different types of antigen (His-tagged
or MBP fusion proteins) and the animals tested.
The antigenicity evaluation results for MBP fusion proteins
MAP2698c and MAP3567 were in agreement with the findings
from a previous study on the evaluation of their His-tagged re-
combinant forms (12). Another recent study reported protein
MAP1272c NlpC/P60 to be strongly antigenic in cattle infected
with M. avium subsp. paratuberculosis (29). Evaluation of this pro-
tein in sheep infected with M. avium subsp. paratuberculosis in this
study also showed strong immunoreactivity, suggesting that this
protein may be of potential use in the diagnosis of JD in both sheep
and cattle. This is the first antigenicity evaluation of the remaining
28 MBP fusion proteins.
Twelve of the 50 MBP fusion proteins included in this study
were previously identified to have a high number of conforma-
tional B cell epitopes, and so they may be useful for detection of M.
avium subsp. paratuberculosis-specific serum antibodies in in-
fected hosts (43). Antigenicity evaluation of these proteins in this
study revealed 75% (9/12 proteins) to be antigenic.
The proteins found to be antigenic were from clusters such as
amino acid metabolism (four proteins), antioxidant enzymes
(four proteins), fatty acid metabolism (six proteins), hypothetical
proteins (three proteins), proteolysis (two proteins), two-compo-
nent response regulators (two proteins), and cellular processes
(three proteins), as well as cell wall synthesis, cell division, ATP
biosynthesis, signal recognition, and a putative virulence factor
(one protein each). These clusters of M. avium subsp. paratuber-
culosis proteins recognized by the host immune system may be
involved in the ability of M. avium subsp. paratuberculosis to evade
host defense mechanisms, which may be augmented by in vivo
expression. Antioxidant enzymes are important for protecting M.
avium subsp. paratuberculosis from the oxidative stress response
mounted by the host (10, 44, 45); similarly, proteins involved in
fatty acid metabolism play important roles in intracellular sur-
vival, growth of mycobacteria, and pathogenicity in mycobacterial
infections (46). Proteins and lipoproteins associated with cell wall
synthesis and lipid membranes are critical for protecting myco-
bacteria from damage (47).
In conclusion, this study has identified several stress-regulated
M. avium subsp. paratuberculosis proteins as being antigenic in
infected sheep. Proteins that were found to be able to detect pauc-
ibacillary infections and Institut Pourquier ELISA low reactors
may be of potential use in early diagnosis. The proteins that were
identified as antigenic in this study (MBP fusion or cleaved) and
TABLE 5 Antigenicity evaluation of His-tagged proteins
Protein
Protein
concn
(g/ml)
OD450 for:
Pa AUCROC
Unexposed
samples
Exposed
samples
MAP1272c 5 0.140 0.318 
0.0001 0.90
MAP2487c 4 0.160 0.297 0.004 0.70
MAP2698c 2 0.149 0.285 0.003 0.685
MAP3567 0.5 0.271 0.443 0.009 0.751
a Mean OD values for the exposed group are significantly higher than those for the
unexposed group (P 
 0.05).
TABLE 6 Comparison of antigenicity of MBP fusion, His-tagged, and
factor Xa-cleaved proteinsa
Protein
Data by protein type
MBP fusion His tagged Factor Xa cleaved
P AUCROC P AUCROC P AUCROC
MAP1272c 0.002 0.728 
0.0001 0.90 NEb NE
MAP2487c 0.331 NE 0.004 0.697 NE NE
MAP2698c 0.150 NE 0.003 0.685 0.007 0.70
MAP3567 0.005 0.703 0.009 0.751 NE NE
a P and AUCROC values are for comparisons between infected and uninfected groups of
sheep. Mean OD values for the exposed group are significantly higher than those for the
unexposed group (P 
 0.05).
b NE, not examined.
TABLE 4 Antigenicity evaluation of MBP fusion and factor Xa-cleaved proteins
Protein
Protein
concn
(g/ml)
Data for MBP fusion proteins Data for factor Xa-cleaved proteins
OD450 (n) for:
Pc AUCROC
OD450 (n) for:
Pc AUCROC
Unexposed samples
(23)
Exposed samples
(23)
Unexposed samples
(23)
Exposed samples
(23)
MAP0593c 20 0.262 0.301 0.295 0.182 0.253 0.005 0.75
MAP1017c 10 0.203 0.266 0.046 0.687 0.206 0.314 0.005 0.753
MAP1588cb 10 0.167 0.243 0.027 0.702 0.153 0.206 0.033 0.662
MAP1846cb 10 0.158 0.239 0.022 0.702 0.178 0.23 0.029 0.708
MAP1885c 10 0.237 0.261 0.659 0.166 0.169 0.864
MAP2280cb 10 0.196 0.279 0.027 0.702 0.239 0.344 0.002 0.786
MAP2698c 4 0.207 0.268 0.15 0.197 0.239 0.007 0.7
MAP3190a,b 10 0.222 0.327 0.007 0.708 0.165 0.224 0.03 0.668
MAP3538b 10 0.172 0.247 0.022 0.703 0.188 0.264 0.001 0.792
MAP3555a,b 10 0.272 0.448 0.002 0.736 0.203 0.311 0.002 0.738
a Proteins able to produce significantly higher OD values for serum samples obtained from sheep with paucibacillary infections than for serum samples from unexposed sheep.
b Proteins able to produce significantly higher OD values for serum samples that were low reactors in the Institut Pourquier ELISA than for serum samples from unexposed sheep.
c Mean OD values for the exposed group are significantly higher than those for the unexposed group (P 
 0.05).
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by Kawaji et al. (His-tagged) (13) may be of potential use in the
diagnosis and control of JD. The antigenicity results for cleaved or
His-tagged M. avium subsp. paratuberculosis proteins were mar-
ginally superior to those for MBP fusion forms. Further evalua-
tion of these proteins using a larger panel of serum samples with-
out the bias of prior positive ELISA results is required to select
potentially useful proteins for diagnosis.
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